Hoechst Allegra Rx antihistamine launched with direct-to-consumer ads.
This article was originally published in The Tan Sheet
Executive Summary
HOECHST Rx ALLEGRA LAUNCH SUPPORTED BY DIRECT-TO-CONSUMER ADS in Aug. 20 newspapers nationwide. With Hoechst Marion Roussel's roll-out of Allegra (fexofenadine) to the prescription market, the product replaces Seldane as the firm's next likely non-sedating antihistamine Rx-to-OTC switch candidate. FDA approved Allegra on July 25 and HMR began shipments Aug. 8.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning